ECCMID 2021
ORAL
Change in antibiotic use during the COVID-19 first wave in French hospitals
A. Chabaud* (Limoges, France), A. Jouzeau, M. Péfau, L. Dugravot, C. Martin, O. Ali-Brandmeyer, C. Rabaud, J. Claver, E. Couve-Deacon, M.C. Ploy, E. Reyreaud, F. Lieutier-Colas, A.M. Rogues, L. Simon, C. Dumartin
Whole genome sequencing for characterisation of respiratory Staphylococcus aureus isolates in the intensive care unit
S. Meyer* (Limoges, France), A.L. Fedou, T. Daix, D. Chainier, A.C. Hernandez-Padilla, M.C. Ploy, P. Vignon, B. François, O. Barraud
Use of broad-spectrum antibiotics according to clinical wards in 1734 hospitals in 2019
A. Jouzeau* (Vandoeuvre-Les-Nancy, France),
A. Chabaud, M. Péfau, L. Dugravot, F. Lieutier-Colas, E. Couvé-Deacon, C. Martin, M.C. Ploy, J. Claver, O. Ali-Brandmeyer, E. Reyreaud, A.M. Rogues, C. Rabaud, L. Simon, C. Dumartin
Improved antibiotic use in 342 nursing homes: data from a national network 2018-2019
F. Lieutier-Colas* (Strasbourg, France), A. Jouzeau, A. Chabaud, M. Péfau, L. Dugravot, E. Couvé- Deacon, C. Martin, J. Claver, O. Ali-Brandmeyer, C. Rabaud, M.C. Ploy, E. Reyreaud, A.M. Rogues, L. Simon, C. Dumartin
Long-term neurological sequelae in adult patients with community-acquired bacterial meningitis
C. Burdet* (Paris, France), S. Akroum, S. Tubiana, T. De Broucker, N. Dournon, E. Baron, M.C. Ploy, B. Mourvillier, E. Oziol, F. Lacassin, H. Laurichesse, B. Hoen, X. Duval
POSTERS
A novel class 1 integron (In1992) carrying blaGES-16 in an extensively drug-resistant Pseudomonas aeruginosa (XDR-PSA) clinical strain in Brazil
A.C. Gales* (Sao Paulo, Brazil), A. Streling, T. Thais Avila Catan, R. Rodrigo Cayo Da Silva, C. Carolina Nodari, F. Fernanda Fernandes Dos Santos, T. Tiago Valiatti, B. Blake Hanson, W. Willian Shopshire, A. An Q. Dinh, T. Thomas Jové, W. William R. Miller, C. Cesar A. Arias, A. Antonio Carlos C Pignatari
VRB-1, a novel class A β-lactamase, in an extensively drug-resistant Pseudomonas aeruginosa (XDR-PSA) isolated in Brazil
A.C. Gales* (Sao Paulo, Brazil), A. Streling, R. Cayo, R. Paes Leme, C. Nodari, F. Fernandes Dos Santos, T. Jove, B. Hanson, W. Miller, W. Shropshire, A. Q. Dinh, S. Zhizeng, T.G. Palzkill, C.A. Arias
Molecular characterisation of in vivo acquisition of ceftolozane/tazobactam and ceftazidime/avibactam resistances in a patient treated for a Pseudomonas aeruginosa infection
L. Deroche* (Poitiers, France), M. Thiry, L. Prouvensier, L. Laval, S. Marchand, M.C. Ploy, W. Couet, O. Barraud, J. Buyck
SARS-CoV-2 clinically significant reinfection documented by PCR, serology, and full genome NGS analysis
S. Alain* (Limoges, France), N. Pestourie, V. Tilloy, S. Hantz, J. Darreye, M. Gomez-Mayeras, E. Guerin, S. Rogez, M.C. Ploy
pUL52: a new potential therapeutic target of human cytomegalovirus DNA-packaging C. Muller* (Limoges, France), G. Ligat, S. Alain, S. Hantz